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Summary
p53 is a tumor suppressor gene whose regulation is
crucial to maintaining genome stability and for the
apoptotic elimination of abnormal, potentially cancer-
predisposing cells. C. elegans contains a primordial
p53 gene, cep-1, that acts as a transcription factor
necessary for DNA damage-induced apoptosis. In a
genetic screen for negative regulators of CEP-1, we
identified a mutation in GLD-1, a translational repres-
sor implicated in multiple C. elegans germ cell fate
decisions and related to mammalian Quaking pro-
teins. CEP-1-dependent transcription of proapoptotic
genes is upregulated in the gld-1(op236) mutant and
an elevation of p53-mediated germ cell apoptosis in
response to DNA damage is observed. Further, we de-
monstrate that GLD-1 mediates its repressive effect
by directly binding to the 3UTR of cep-1/p53 mRNA
and repressing its translation. This study reveals that
the regulation of cep-1/p53 translation influences
DNA damage-induced apoptosis and demonstrates
the physiological importance of this mechanism.
Introduction
The central role of p53 as a tumor suppressor is de-
monstrated by the fact that most human cancers
evolve ways to evade p53 tumor suppressor activity,
particularly its transcriptional activation function (Roe-
mer, 1999; Pierotti and Dragani, 1992; Vogelstein et al.,*Correspondence: a.gartner@dundee.ac.uk
4Present address: Department of Genetics, Erasmus MC, 3015 GE
Rotterdam, Netherlands.
5Present address: GlaxoSmithKline, Comparative Genomics, 1250
South Collegeville Road, Collegeville, Pennsylvania 194269.
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Dow Street, Dundee, DD1 5EH, United Kingdom.2000). Although human cancers commonly contain
mutations in the p53 gene itself, many of the remaining
tumors have defects in upstream signaling components
of the p53 pathway such as inactivation of the positive
regulators ARF or CHK2 (Sharpless and DePinho, 1999;
Bartek and Lukas, 2003), or overexpression of the
negative regulator Mdm2 (Freedman et al., 1999). For
those tumors that retain functional p53 but have ampli-
fication of Mdm2, therapeutic strategies have been
developed to inhibit Mdm2, whereby increased p53
protein levels make tumor cells more susceptible to
p53-mediated apoptosis (Chene, 2003; Lain and Lane,
2003; Vassilev et al., 2004). Such a therapeutic ap-
proach highlights the need to uncover additional path-
ways and mechanisms that negatively regulate p53
levels or activity.
Most studies on p53 signaling have been conducted
in cell culture-based systems, and their translation into
mouse models is often hampered by the fact that some
regulatory mechanisms which exist in tissues and or-
ganisms are not present in cell culture and that some
p53 regulators are likely to be essential for organismal
viability. C. elegans contains a primordial p53 gene,
cep-1 (C. elegans p53), that is necessary for DNA dam-
age-induced apoptosis and acts as a transcription
factor (Derry et al., 2001, Schumacher et al., 2001). The
apparent absence of an Mdm2 homolog (WormBase
website, http://www.wormbase.org), leads to the hy-
pothesis that novel, possibly evolutionarily conserved
mechanisms for negatively regulating cep-1/p53 exist
in C. elegans. Therefore, we have taken a forward ge-
netic approach, an unbiased genetic screen to identify
negative regulators of cep-1/p53, to isolate mutants
with increased apoptosis and upregulated p53 sig-
naling.
In adult hermaphrodite worms, the germline resides
in two U-shaped gonads where different germ cell
types are spatially arranged in a gradient of maturation,
which includes a distal proliferative stem cell compart-
ment, entry into meiotic prophase that coincides with
the early stages of meiotic chromosome pairing (transi-
tion zone), and the various subsequent stages of mei-
otic prophase, early and late pachytene, as well as dip-
lotene and diakinesis that go hand in hand with oocyte
growth and differentiation (Figure 5A, top panel; Hub-
bard and Greenstein, 2000; Seydoux and Schedl, 2001).
The organization of the hermaphrodite germline is remi-
niscent of mammalian male germline development and
may involve similar regulatory mechanisms (Tunquist
and Maller, 2003), and pachytene cells can undergo
apoptotic demise that often involves p53 signaling (Co-
hen and Pollard, 2001; Cooke and Saunders, 2002;
Matzuk and Lamb, 2002).
In C. elegans, several pathways can lead to germ cell
apoptosis during meiotic development (Hofmann et al.,
2000). Physiological germ cell apoptosis is thought to
control germ cell number homeostasis whereas DNA
damage-induced apoptosis involves a conserved set of
Cell
358upstream checkpoint proteins needed to eliminate cells a
pthat received DNA damage (Gumienny et al., 1999;
Gartner et al., 2000). Both of these germ cell apoptosis s
Fpathways use the same apoptotic core machinery as
somatic cell death occurring during embryogenesis l
q(Figure 2, top panel; Gumienny et al., 1999; Gartner et
al., 2000). In mitotically dividing germ cells, however, (
Echeckpoint signaling, which requires the same upstream
DNA damage checkpoint proteins as DNA damage- w
finduced apoptosis, leads to transient cep-1/p53-inde-
pendent cell cycle arrest without apoptosis (Gartner et g
sal., 2000; Derry et al., 2001; Schumacher et al., 2001).
By contrast in pachytene cells, upon ionizing radiation N
i(IR) CEP-1/p53 transcriptionally induces the BH3 do-
main-only protein EGL-1 (Hofmann et al., 2002), analo- b
Fgous to mammalian p53 induction of BH3 domain-only
proteins (Villunger et al., 2003). t
STo identify new components of CEP-1/p53 regulation,
we conducted a genetic screen for mutations that en- 1
uhance p53 signaling. One such mutation, op236, affects
the conserved GLD-1 protein, leading to the elevation 1
aof p53-mediated germ cell apoptosis in response to
DNA damage while multiple other developmental func- t
gtions of GLD-1 remain unaffected. We show that GLD-1
mediates its repressive effect by directly binding to the f
23#UTR of cep-1/p53 mRNA and repressing translation.
c
pResults
(
tA Genetic Screen for Negative Regulators of p53
eIdentifies a Novel Mutation in the C. elegans
uGermline Tumor Suppressor GLD-1
pTo identify genes that downregulate the p53 pathway
tin C. elegans, we conducted a genetic screen to find
smutants that showed increased levels of apoptosis upon
olow doses of IR (Supplemental Note 1 at http://www.cell.
tcom/cgi/content/full/120/3/357/DC1/). Two such mu-
ptants, op236 and op237, showed a strong up-
rregulation of apoptosis following IR (Figures 1A and 1B
dand data not shown) without a concomitant defect in
gDNA repair activity (see below). Both mutations are re-
pcessive and fail to complement each other, indicating
gthat they are alleles of the same gene (data not shown).
sPositional cloning (Supplemental Data) and sequence
(analysis revealed that both mutants carry the same
sDNA alteration, a G to T transversion at nucleotide po-
ssition 826 of the C. elegans germline tumor suppressor
gld-1 (T23G11.3), leading to a Valine to Phenylalanine
substitution at amino acid 276, which lies in the GSG/ T
SSTAR RNA binding domain (Jones and Schedl, 1995;
Supplemental Figure S1a). Valine 276 is conserved in T
fDrosophila and human GLD-1 homologs, Who/How
and Quaking, respectively. gld-1-null mutant hermaph- w
Wrodites have germline tumors as pachytene germ cells
fail to maintain the oocyte differentiation pathway and 1
gre-enter the mitotic cell cycle. Other classes of gld-1
alleles display feminization of the germline, masculinar- m
uization of the germline, or undifferentiated germline
phenotypes (Francis et al., 1995a). However, none of c
tthe known gld-1 alleles have been implicated in apo-
ptosis. That the excess apoptosis phenotype of op236 v
uis due to a defect in gld-1 function is indicated by the
failure of gld-1(null) to complement the op236 excess ppoptosis phenotype and, conversely, a transgene ex-
ressing wild-type GLD-1 rescuing the excess apopto-
is phenotype (Supplemental Note 2 and Supplemental
igure S1b). GLD-1 has been shown to bind and trans-
ationally repress a number of target mRNAs and is re-
uired for multiple aspects of germline development
Jan et al., 1999; Lee and Schedl, 2001, 2004; Marin and
vans, 2003; Xu et al., 2001; Mootz et al., 2004). To test
hether gld-1(op236) has any of the developmental de-
ects characteristic of other gld-1 alleles, we looked at
ermlines of gld-1(op236) worms grown at 20°C (the
tandard temperature for propagating C. elegans) by
omarski optics (not shown) as well as by DAPI stain-
ng. In both assays, the gld-1(op236) germlines resem-
led wild-type germlines (Supplemental Figure S2a).
urthermore, GLD-1 staining was not altered in wild-
ype and gld-1(op236) worms (Supplemental Figure
2a). Interestingly, the germlines of gld-1(op236)/gld-
(null) were feminized, indicating that gld-1(op236) is
nable to rescue the sex-determination defect of gld-
(null) (data not shown). Because gld-1(op236) worms
re essentially wild-type with the exception of their ex-
ra germ cell death phenotype, we wondered whether
ld-1(op236) might display temperature-sensitive de-
ects and examined mutants at 25°C. When grown at
5°C, gld-1(op236) animals indeed showed a dramati-
ally increased level of germ cell apoptosis as com-
ared to wild-type worms even in the absence of IR
Figure 3A). Affected germlines were smaller than wild-
ype and showed an extended pachytene region at the
xpense of oocytes (Figure 6C and Supplemental Fig-
res S2b and S5a). The extended pachytene region ap-
ears to be a result of a delayed transition from pachy-
ene to diakinesis with few or no diplotene oocytes at
teady state, unlike wild-type germlines that have an
rdered progression of oocytes from late pachytene
hrough diplotene and diakinesis (Figure 6C and Sup-
lemental Figures S2b and S5a). This phenotype is
eminiscent of germlines where apoptosis is highly in-
uced such as in ced-9(lf) or highly irradiated wild-type
ermlines where almost all pachytene cells die by apo-
tosis in late pachytene and hence, only very few pro-
ress further in oogenesis, resulting in a very low
teady state level of diplotene and diakinesis oocytes
our unpublished data). We will refer to 25°C as the re-
trictive temperature for gld-1(op236) and 20°C as the
emipermissive temperature.
he gld-1(op236) Mutation Affects cep-1/p53
ignaling upon DNA Damage
o assess whether gld-1(op236) might specifically af-
ect the cep-1/p53 pathway, the following experiments
ere performed (at the semipermissive temperature).
e evaluated whether the apoptotic phenotype of gld-
(op236) is due to DNA damage per se or due to a
eneral stress response, such as oxidative stress that
ay also be caused by IR. To this end we generated
nprocessed double-strand breaks in meiotic germ
ells without IR by inactivation of Ce-rad-51, the func-
ional homolog of bacterial recA, involved in strand in-
asion during meiotic recombination, which leads to
nprocessed meiotic recombination intermediates in
achytene cells and cep-1/p53-dependent apoptosis
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359Figure 1. gld-1(op236) Specifically Upregulates DNA Damage-Induced Apoptosis at the Semipermissive Temperature
Wild-type and op236 mutant hermaphrodites (at 20°C) were irradiated at the L4 larval stage and apoptosis and cell cycle arrest was deter-
mined by Nomarski optics.
(A) Upon IR, gld-1(op236) shows an increased number of germ cell corpses (arrows) as seen by Nomarski optics.
(B) Quantification of germ cell corpses. Hermaphrodites (at 20°C) were irradiated at the L4 larval stage and the number of corpses was
counted after the indicated time points. Error bars represent the standard error of the mean (SEM). For each dose and time point, 21 to 67
germlines were scored.
(C) Meiotic recombination intermediates hyper-induce apoptosis in gld-1(op236). Wild-type (n = 16) and gld-1(op236) hermaphrodites (n = 28)
were injected with double-strand rad-51 RNA and progeny of rad-51-depleted animals were analyzed for germ cell apoptosis (Gartner et al.,
2000, 2004).
(D) gld-1(op236) does not affect the mitotic cell cycle arrest checkpoint response. Wild-type and gld-1(op236) mitotic cells similarly decrease
in number, within a defined volume, but increase in size as they arrest upon DNA damage (n = 4 to 12) (Supplementary Note 3). In the right
upper panel representative pictures of mitotic cells before and after irradiation are shown.
(E) gld-1(op236) is not hypersensitive to DNA damage. Hermaphrodites (n = 18) were irradiated at the L4 stage, transferred 24 hr post-
irradiation, and allowed to lay eggs for 12 hr. Egg laying rates are indicated per animal and hour. Progeny survival was counted 36 hr later.
Relative egg laying indicates the percentage of eggs laid in comparison to untreated worms (0 Gy) of the same genotype.
Cell
360(Alpi et al., 2003; Gartner et al., 2000). Given that apo- s
tptosis is increased following rad-51 RNAi in gld-
1(op236)mutants at the semipermissive temperature as s
ccompared to wild-type, this is likely a specific response
to damaged DNA (Figure 1C). The increased apoptosis p
tin gld-1(op236) in response to IR and Ce-rad-51 RNAi
could be caused by defects in DNA repair or a specific g
supregulation of the p53 apoptotic signaling pathway
which in C. elegans only affects IR-induced cell death t
Gand not DNA repair (Derry et al., 2001; Schumacher et
al., 2001). DNA double-strand repair mutants, upon a
gtreatment with IR, display increased levels of germ cell
apoptosis and progeny lethality due to unrepaired DNA t
damage (Boulton et al., 2002). To evaluate whether gld-
1(op236) is deficient in repairing damaged DNA, we G
measured DNA damage sensitivity by scoring levels of c
progeny survival (at the semipermissive temperature) A
after IR (Gartner et al., 2000; Figure 1E). Following IR, 1
the number of fertilized eggs drops more dramatically t
in gld-1(op236) as compared with wild-type, most likely s
as a result of increased germ cell death as the drop in t
the number of fertilized eggs can be largely rescued by w
a p53/cep1(null) mutant (also see below, Figure 1E). b
The progeny of gld-1(op236) animals, as well as the m
progeny of gld-1(op236) cep-1(null) double mutants, w
however, show the same survival rate as the progeny t
of wild-type worms and cep-1(null) worms. We next 1
carefully analyzed the DNA damage-dependent cell cy- t
cle arrest phenotype, and consistent with the notion s
that gld-1(op236) and wild-type worms are equally sen- s
sitive to IR we found a similar drop in mitotic cell I
number in gld-1(op236) and wild-type with increasing i
dose of IR (Figure 1D), arguing that gld-1(op236) is not i
irradiation sensitive or affects upstream checkpoint sig- w
naling (Supplemental Note 3; Figure 1D) (Gartner et al., T
2000, 2004). In summary, these results suggest that the g
gld-1(op236) mutation specifically affects the p53/cep- d
1pathway to upregulate the apoptotic response to o
DNA damage. 1
l
eGenetic Epistasis Analysis with gld-1(op236)
mWe next evaluated whether the enhanced germ cell
odeath in gld-1(op236) upon IR is dependent on the core
Capoptotic machinery (Figure 2A). We asked whether
gloss-of-function alleles of the C. elegans apoptosis
tgenes, ced-3 and ced-4, as well as a gain-of-function
lallele of ced-9 would suppress the gld-1(op236) pheno-
(type. Loss-of-function mutations ced-3(n717) and ced-
s4(n1162) completely suppressed and a gain-of-function
nallele of ced-9(n1950) very strongly suppressed apo-
ptosis [gld-1(op236); ced-3(n717) 0 ± 0 germ cell
corpses (n > 15), gld-1(op236); ced-4(n1162) 0 ± 0 germ G
Gcell corpses (n > 15), gld-1(op236); ced-9(n1950) 1.3 ±
0.3 germ cell corpses (n = 15), 24 hr post 60 Gy of IR, all a
oat 20°C], suggesting that gld-1(op236) acts upstream of
the core cell death pathway (Figure 2A). s
cTo further determine where gld-1 acts in DNA dam-
age-induced apoptosis, we performed genetic epista- (
fsis analysis with genes that act upstream of the core
apoptotic machinery. A deletion mutant of cep-1/p53 g
malmost completely suppressed gld-1(op236) IR-induced
apoptosis while a null mutation in the CEP-1/p53 target P
dgene egl-1 strongly suppressed gld-1(op236) at theemipermissive temperature (Figure 2B). Furthermore,
he increased cell death of gld-1(op236) at the re-
trictive temperature was also largely dependent on
ep-1/p53 and egl-1 as both mutants strongly sup-
ressed the gld-1(op236) extra cell death phenotype at
his temperature (Figure 3A). These results suggest that
ld-1(op236) affects cep-1/p53 signaling at both the
emipermissive and the restrictive temperatures and
hat it acts upstream or at the same level as cep-1/p53.
iven that the gld-1(op236) extra cell death phenotype
t 25°C is not completely suppressed by cep-1/p53,
ld-1 is likely to act on another, as of now uncharac-
erized gene(s), besides cep-1.
LD-1 Downregulates
ep-1/p53-Dependent Transcription
s apoptosis in gld-1(op236) is dependent on the cep-
/p53 pathway, we first tested whether CEP-1/p53 ac-
ivity is upregulated in gld-1(op236) worms grown at the
emipermissive temperature. To assess CEP-1/p53 ac-
ivity in vivo, we measured the transcript levels of egl-1,
hich was previously shown to be a CEP-1/p53 target,
y quantitative real-time PCR (qPCR) (Figure 2C) (Hof-
ann et al., 2002). When wild-type and gld-1(op236)
orms were compared, egl-1 transcript levels were fur-
her increased by approximately 2- to 3-fold in gld-
(op236) worms (Figure 2C). We also tested whether
he cep-1/p53 pathway was upregulated at the re-
trictive temperature, where gld-1(op236) showed a
trong increase in apoptosis, even in the absence of
R (Figure 3A). egl-1 mRNA levels in gld-1(op236) were
ndeed elevated at the restrictive temperature and this
ncrease in egl-1 mRNA levels following DNA damage
as also dependent on cep-1/p53 (Figures 3B and 3C).
herefore, we conclude that the apoptotic induction in
ld-1(op236) at the restrictive temperature is largely
ue to the upregulation of the p53 pathway. If the level
f egl-1 is upregulated in a partial loss-of-function gld-
(op236), then the level of egl-1 should also be upregu-
ated in a gld-1-null allele. To test this, we measured
gl-1 mRNA levels in gld-1(null) and found that egl-1
RNA levels were indeed upregulated, 6.04 (±0.41)-fold
ver wild-type. We conclude that GLD-1 represses
EP-1 activity and this repressive effect is defective in
ld-1(op236) mutants. To confirm that egl-1 transcrip-
ion generally reflects p53 activity, we measured mRNA
evels of another transcriptional target of p53, ced-13
Schumacher et al., 2005), which indeed showed the
ame GLD-1 and irradiation dependency as egl-1 (data
ot shown).
LD-1 Binds to cep-1 mRNA
iven that GLD-1 has previously been characterized as
n mRNA binding protein that represses the translation
f target mRNAs (Lee and Schedl, 2001, 2004), it
eemed plausible that GLD-1 might directly bind the
ep-1/p53 mRNA. To test this, we immunoprecipitated
IP) FLAG-tagged GLD-1 from cytosol extracts derived
rom adult hermaphrodites containing a gld-1::flag trans-
ene and reverse transcribed the coprecipitated
RNAs, which were then subjected to semiquantitative
CR amplification using primers directed against can-
idate genes. Using this strategy, we found an enrich-
Translational Repression of C. elegans p53 by GLD-1
361Figure 2. Genetic Analysis of gld-1(op236) Reveals that gld-1 Acts Upstream or at the Same Level as cep-1/p53
(A) A diagram of the DNA damage checkpoint pathway is shown. Note that in C. elegans DNA damage-induced apoptosis but not cell cycle
arrest or DNA repair is dependent on cep-1/p53.
(B) Apoptosis in gld-1(op236) is dependent on cep-1/p53 and egl-1. Hermaphrodites were irradiated and analyzed as in Figure 1 (n = 8 to 67
for each data point). egl-1(n1084n3082) null mutation is referred to as egl-1 and the deletion mutant cep-1(lg12501) is referred to as cep-1.
(C) Quantitative real-time PCR (qPCR) to measure egl-1 mRNA levels. L4 hermaphrodites treated with IR and total RNA were isolated after
20 hr. Levels were normalized to γ tubulin mRNA. Fold induction was calculated relative to levels in nontreated wild-type worms. In the
representative experiment shown, qPCRs were done in duplicate; error bars represent SEM.
(D) Quantification of cep-1 mRNA levels (egl-1 qPCR was done as internal control).ment of cep-1/p53 mRNA, similarly to the positive con-
trols rme-2 and gna-2, while there was no enrichment
of ced-9, ced-4, ced-3, or egl-1 mRNAs (Figure 4A).This indicates that GLD-1 preferentially binds to the
cep-1/p53 mRNA. To confirm the interaction of GLD-1
with cep-1/p53 mRNA and to narrow down the GLD-1
Cell
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dent egl-1 Transcription and Apoptosis at the Restrictive Temper- w
ature S
(A) Hermaphrodites at L4 larval stage were shifted to 25°C and t
germ cell corpses were quantified after 24 hr (n = 26 to 68). Error m
bars represent SEM. p
(B) Hermaphrodites were treated as in (A), total RNA was isolated
l20 hr post-temperature shift, and egl-1 transcript levels were mea-
lsured by qPCR. Fold induction was calculated relative to levels in
nontreated wild-type hermaphrodites at 20°C. m
(C) qPCR comparing the fold-induction of cep-1 and egl-1 mRNA t
levels at 25°C versus 20°C from wild-type and gld-1(op236) worms S
as also shown in Figure 2D. p
u
rbinding region, we asked whether biotinylated cep-1/ l
p53 mRNA subfragments can coprecipitate GLD-1 pro- a
tein from cytosol extracts (Figure 4B). We found that m
only biotinylated cep-1/p53 mRNA subfragments that
contained the 3#UTR of the cep-1/p53 mRNA coprecip- p
itated GLD-1 protein from worm extracts (Figure 4B, m
lower panel). When the same concentration of cep-1 d
mRNA and three previously characterized targets, e
rme-2, tra-2, and gna-2 mRNAs (Lee and Schedl, 2001, p
2004), were tested for GLD-1 binding, cep-1mRNA was f
bound less efficiently (Figure 4C). This suggests that o
the affinity of GLD-1 for the cep-1 mRNA is relatively s
tlower than for rme-2, tra-2, and gna-2 mRNAs. Whene used cytoplasmic extracts from gld-1(op236) adult
ermaphrodites, the interaction of the cep-1/p53
#UTR with GLD-1(op236) was dramatically reduced,
ndicating that GLD-1(op236) is defective in binding to
ep-1 mRNA (Figure 4C). In contrast, GLD-1(op236)
inding to rme-2, tra-2, and gna-2 mRNAs is relatively
naffected (Figure 4D). In summary, our data suggest
hat GLD-1 specifically binds to the cep-1/p53 3#UTR
nd that the interaction of GLD-1(op236) with cep-1
RNA is dramatically reduced while it retains sufficient
inding to at least three other target mRNAs. This is
onsistent with the notion that GLD-1(op236) might be
roficient in most, if not all, GLD-1 functions except its
ffect on cep-1-dependent apoptosis at the semi-
ermissive temperature. Therefore, gld-1(op236) may
e specifically defective in interaction with the cep-1
RNA while binding to other targets remains suffi-
iently strong.
LD-1 Represses the Translation
f cep-1/p53 mRNA
s GLD-1(op236) has specifically lost its interaction
ith cep-1/p53 mRNA, we next asked how GLD-1
ownregulates cep-1/p53. We first addressed whether
LD-1 affects cep-1 transcript levels. We found that
ep-1/p53 transcript levels in gld-1(op236) worms at
he semipermissive or the restrictive temperatures,
ollowing IR, or in gld-1(null) animals are similar to cep-1/
53 transcript levels in wild-type animals (Figures 2D
nd 3C and Supplemental Figure S3). Since GLD-1 has
een shown to repress the translation of a number of
arget mRNAs (Jan et al., 1999; Lee and Schedl, 2001,
004; Marin and Evans, 2003; Xu et al., 2001; Mootz et
l., 2004), we asked whether GLD-1 represses cep-1/
53 translation. To assess CEP-1/p53 protein levels, we
aised polyclonal antibodies to CEP-1/p53 and stained
ild-type adult hermaphrodite germlines (Figure 5A and
upplemental Figure S4). CEP-1/p53 is abundant in mi-
otically dividing distal germ cells. Upon the entry into
eiotic prophase in the transition zone, CEP-1/p53
rotein is completely absent. CEP-1/p53 reappears in
ate meiotic pachytene cells and remains up to the dip-
otene/early diakinesis stage (Figure 5A and Supple-
ental Figure S4). Subcellularly, CEP-1/p53 is localized
o the nucleoplasm (Figure 5A and Supplemental Figure
4) and the concentration and/or localization of CEP-1/
53 is apparently unaffected by IR (Supplemental Fig-
res S6c and S6d). Furthermore, there is a reciprocal
elationship between CEP-1/p53 and GLD-1 protein
evels, as CEP-1/p53 is only high where GLD-1 levels
re low, consistent with the hypothesis that GLD-1
ight repress the translation of cep-1 mRNA (Figure 6A).
We next asked whether CEP-1/p53 protein is misex-
ressed and/or whether its levels are increased in gld-1
utants. We found a dramatic misexpression and a
ramatic increase in levels of CEP-1/p53 protein in
arly meiotic prophase germ cells in gld-1(null) as com-
ared with wild-type animals (note the exposure time
or the gld-1(null) germline isw5 times shorter than the
ther pictures; Figure 5B versus 5A). Similarly, when we
tained gld-1(op236) worms grown at the restrictive
emperature, we observed increased levels of CEP-1/
Translational Repression of C. elegans p53 by GLD-1
363Figure 4. GLD-1 but Not GLD-1(op236) Binds to the 3#UTR of cep-1/p53 mRNA
(A) Cytosol extracts from hermaphrodites containing a transgene expressing a GLD-1::FLAG fusion protein were used for coimmunoprecipita-
tion of mRNAs, and the relative level of the precipitated mRNA for the indicated cell death genes, as wells as for the positive controls rme-2
and gna-2, was assessed by cDNA synthesis and subsequent semiquantitative PCR reactions. In the left column, semiquantitative PCRs of
total RNA; in the middle column, RNA from the control IgG IP; and in the right column, RNA from the FLAG IP are shown. In the lower panel,
a Western blot indicating the specificity of the FLAG precipitation is shown. Upon precipitation with control IgG and anti-FLAG antibodies
the immunoprecipitates were eluated with FLAG peptides and the eluates (E1 to E5) were subjected to Western blot analysis.
(B) Mapping the region of the cep-1 mRNA that binds GLD-1. Each biotinylated cep-1 mRNA subfragment, as indicated in the upper panel
(400 ng or no RNA), was incubated with increasing amount of cytosol extract (50 ng and 150 ng total protein, small and large open bars,
respectively) from adult wild-type (lower B panel and in [C]) or gld-1(op236) mutant hermaphrodites (D). GLD-1 was detected via Western
analysis using anti-GLD-1 antibodies. MH16, an anti-Paramyosin antibody, was used for control Western blot.
(C) Comparison of cep-1 binding with known GLD-1 targets. Biotinylated mRNAs (80 nM) of cep-1, rme-2, tra-2, and gna-2 were used to
assess their interaction with wild-type GLD-1.
(D) GLD-1(op236) specifically affects cep-1 mRNA binding.p53 protein that accumulated in more distal pachytene
nuclei as compared with wild-type animals grown at the
same temperature (Figure 5A and Supplemental Figure
S5a). As expected from the phenotype and the RNA
binding data, GLD-1(op236) was still able to repress the
translation of another GLD-1 target, rme-2 mRNA, at
both temperatures (Supplemental Figures S5a and
S5b). When gld-1(op236) hermaphrodites grown at thesemipermissive temperature were examined, CEP-1/
p53 protein levels as well as the number of CEP-1/p53-
positive cells appeared slightly higher as compared to
wild-type (Supplemental Figure S6a). This finding was
supported by careful examination of many germlines
where we found that the CEP-1/p53 accumulated in
slightly but significantly more pachytene nuclei in gld-
1(op236) than in wild-type (Figure 5C). As expected, we
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(A) Wild-type (upper) and gld-1(op236) (lower) germlines from hermaphrodites grown at the restrictive temperature (25°C) and dissected 16
hr post L4 larval stage and stained with anti-CEP-1 antibodies (green) and DAPI (blue). To detect quantitative differences in staining intensities,
nonsaturating pictures were taken. The various stages of germ cells in the dissected gonad are indicated in the corresponding upper DAPI-
stained germlines.
(B) gld-1(null) worms (grown at 20°C) were dissected 24 hr post L4 and treated similarly as in (A) but exposure time was w5 times shorter,
indicative of highly upregulated CEP-1/p53 levels.
(C) Quantification of the number of pachytene germline nuclei with CEP-1 staining in wild-type and gld-1(op236) at the restrictive temperature
(25°C) as well as at the semipermissive temperature in the presence and absence of IR treatment (n = 11–15). The number of CEP-1-positive
pachytene cells (as defined by their DAPI morphology) was identified by their distinct nuclear CEP-1 staining in dissected germline prepara-
tions.
(D) Dissected germline of a CEP-1::GFP fusions with the 3#UTR of cep-1/p53 (top panel) and with the 3#UTR of let-858 (bottom panel). Note
that the distal tip cell area of the germline in the bottom panel is out of focus. The CEP-1::GFP fusion transgene only leads to partial rescue
of the IR-induced apoptosis phenotype of cep-1(null), possibly because the GFP fusion, which is close to the CEP-1/p53 tetramerization
domain, compromises its activity (R.H. and M.H., unpublished data).could confirm elevated levels of CEP-1/p53 protein by d
lWestern blotting in gld-1(null) total worm extracts but
not in gld-1(op236) worms grown at the restrictive or o
cthe semipermissive temperatures. This suggests that
the elevated levels of CEP-1/p53 in gld-1(op236) c
ppachytene cells are difficult to detect in total worm ex-
tracts, presumably due to the abundant CEP-1/p53 ex- 1
spression in many somatic tissues not regulated by
gld-1 (Derry et al., 2001), (B.S. and A.G., unpublished 3
odata; Supplemental Figure S6b). In conclusion, our re-
sults suggest that GLD-1 acts as a translational repres- e
fsor of cep-1/p53 mRNA. Complete gld-1 loss-of-func-
tion leads to the most dramatic de-repression of cep-1/ o
tp53 translational inhibition, while gld-1(op236) at the
restrictive temperature leads to an intermediate effect, G
tand at the semipermissive temperature leads to a weak
de-repression of translational inhibition. These data in- Ticate that translational repression of cep-1/p53 is
ikely mediated by the binding of GLD-1 to the 3#UTR
f the cep-1/p53 mRNA. If correct, the exchange of the
ep-1 3#UTR with an unrelated 3#UTR that does not
onfer GLD-1 regulation should lead to ectopic CEP-1/
53 accumulation similar to what is observed in gld-
(null). To test this, we constructed a CEP-1::GFP fu-
ion where the cep-1/p53 3#UTR is replaced with the
#UTR of the let-858 gene, which is expressed through-
ut the germline (Kelly et al., 1997) and assessed its
xpression in the presence of wild-type GLD-1. We
ound that this construct leads to ectopic accumulation
f CEP-1/p53::GFP similar to the CEP-1 staining pat-
ern observed in gld-1(null) germlines, whereas a CEP-1::
FP construct containing the cep-1/p53 3#UTR showed
he wild-type pattern of CEP-1 staining (Figure 5D).
herefore, we conclude that GLD-1 translationally re-
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gans Germline
(A) Reciprocal relationship between CEP-1/
p53 and GLD-1 protein levels. Double stain-
ing with anti-CEP-1 antibodies and anti-GFP
antibodies of germlines from gld-1(null);
ozIs2 adult hermaphrodites expressing a
GLD-1::GFP fusion protein (the GLD-1::GFP
staining pattern resembles endogenous
GLD-1 protein). To detect quantitative differ-
ences in staining intensities, nonsaturating
pictures were taken and thus lower levels of
GLD-1 in the mitotic region and distal transi-
tion zone are not observed under these con-
ditions.
(B) Model for cep-1/p53 regulation. Upper
panel: The reciprocal relationship between
CEP-1 (green) and GLD-1 (red) protein levels
is shown. CEP-1/p53 (green) levels in gld-1
mutants are indicated by dotted and dashed
curves. Furthermore, the zones of apoptosis
in wild-type and gld-1(op236) hermaphro-
dites grown at the restrictive temperature are
indicated by the solid and the dashed green
lines, respectively. The various stages of
germline development in the upper part of
the panel are roughly aligned with the germ-
line shown in (A). We note that in the transi-
tion zone an activity, in addition to GLD-1, is
likely downregulating CEP-1/p53 levels.
Lower panel: Model depicting antagonistic
relationship between GLD-1 and CEP-1/p53.
In early pachytene cells, high GLD-1 levels
repress cep-1/p53 mRNA translation and
DNA damage does not lead to apoptotic cell
death due to the absence of CEP-1/p53. In
late pachytene cells, where GLD-1 levels are
falling, cep-1/p53 mRNA is translationally
de-repressed and hence CEP-1/p53 can re-
spond to DNA damage stimuli.
(C) Excess apoptosis in gld-1(op236) germ-
lines at the restrictive temperature. Triple
staining in wild-type and gld-1(op236) strains
containing an integrated transgene express-
ing a CED-1::GFP fusion protein; DAPI (blue),
anti-CEP-1 (red), and anti-GFP (green) were
used to detect CED-1. CED-1 staining is
found in somatic sheath cells that surround the germline. In apoptotic germ cells, which are engulfed by sheath cells, CED-1::GFP staining
surrounds the corpse (Zhou et al., 2001). Both the number of germ cells and the distal-proximal region of the germline that contains CED-1::
GFP that surrounds apoptotic germ cells is larger in gld-1(op236) than wild-type.presses the cep-1/p53 mRNA by binding to the 3#UTR
and alleviation of this repression leads to the accumula-
tion of CEP-1/p53 protein.
Discussion
We undertook a genetic screen to identify regulators of
the p53 pathway in C. elegans and discovered GLD-1 as
a negative regulator of CEP-1. gld-1(op236) is a tem-
perature-sensitive allele that at the semipermissive
temperature leads to upregulation of cep-1/p53-depen-
dent germ cell apoptosis synergistically with DNA dam-
age signaling. At the restrictive temperature cep-1/p53-
dependent germ cell apoptosis is upregulated even
without DNA damage. In wild-type germlines, CEP-1/
p53 protein levels are tightly regulated in the early
stages of meiotic prophase by GLD-1. CEP-1/p53 levelsare very low in the transition zone and early pachytene
cells where GLD-1 levels are high in the cytoplasm. As
GLD-1 levels decrease in late pachytene cells, CEP-1/
p53 levels increase (Figures 6A and 6B, upper panel).
In wild-type animals, the upregulation of CEP-1/p53
protein in late pachytene cells through alleviation of
GLD-1-mediated translational repression is not suffi-
cient to trigger apoptosis. We postulate that other
events such as DNA damage-dependent phosphoryla-
tion of conserved CEP-1/p53 residues are likely re-
quired for its full function as a transcriptional activator
of egl-1 expression (Figure 6B). In gld-1(op236) worms
grown at the semipermissive temperature, CEP-1 levels
are only partially upregulated and we postulate that
GLD-1(op236) is partially defective in binding to the
cep-1/p53 3#UTR in vivo (Figure 6B). Under these con-
ditions, CEP-1/p53-mediated apoptosis still requires
Cell
366the DNA damage signal but is dramatically enhanced s
adue to the elevated CEP-1/p53 levels. In gld-1(op236)
worms grown at the restrictive temperature, GLD-1 s
pbinding to the cep-1/p53 3#UTR is likely further de-
creased, leading to further elevated levels of CEP-1/ w
ap53 protein as well as to the apparent misexpression
of CEP-1/p53 in early pachytene cells (Figures 5A and p
c6C). Given that DNA damage-independent but cep-1/
p53-dependent apoptosis occurs in gld-1(op236) mu- t
2tants at the restrictive temperature, we think that CEP-1/
p53 protein levels become sufficiently high to trigger e
mapoptosis without further activation of CEP-1/p53 by
the DNA damage pathways. At the restrictive temper- m
tature, however, other unknown GLD-1 targets that are
involved in germline differentiation and apoptosis are b
olikely misexpressed, which may explain the more se-
vere germline phenotype and the relative increase in h
ecep-1/p53-independent germ cell death (Figure 3A). In
gld-1(null) germlines, the maximal de-repression of l
oCEP-1/p53 translational inhibition occurs due to the ab-
sence of GLD-1 protein. In gld-1(null) germlines, how- g
eever, we do not observe excessive apoptosis despite
high CEP-1/p53 levels (data not shown); this is likely b
ndue to the very low number of late pachytene cells,
which is the only germ cell type that undergoes apopto- l
isis, since in gld-1(null) germlines early pachytene cells
revert to mitotic proliferation (Francis et al., 1995a, s
e1995b).
At present we do not know the exact binding site(s) p
cof GLD-1 in the cep-1 3#UTR. Recently, it has been
shown that a hexanucleotide sequence in tra-2 3#UTR i
5is important for GLD-1 binding in vitro and that this se-
quence is present in 3#UTRs of known GLD-1 targets e
(Ryder et al., 2004). Interestingly, the hexanucleotide
sequence is present in the cep-1 3#UTR as well as in c
mthe 3#UTR of the C. briggsae cep-1 orthologous gene,
CBG04081. However, mutational alterations in this se- v
tquence in the cep-1 3#UTR did not affect GLD-1 bind-
ing while the same mutations in the GLD-1 binding re- T
qgions of rme-2 nearly abolished binding (M.-H.L. and
T.S., unpublished data). Thus further studies will be a
anecessary to define the GLD-1 binding sequences in
the cep-1 mRNA. Moreover, GLD-1 might act together g
swith other proteins as a RNP complex to repress cep-1
translation. H
(We propose that GLD-1 acts as a molecular rheostat
to control CEP-1/p53 accumulation so that a threshold t
plevel is achieved in late pachytene that ensures respon-
siveness to DNA damage pathways (Figure 6B). Given m
athe reciprocal relationship between CEP-1/p53 and
GLD-1 protein levels during mid to late pachytene, G
cGLD-1 regulation of CEP-1 protein levels is likely to be
a part of the mechanism that ensures that only late m
wpachytene cells have the potential to die in response to
genotoxic insults. Indeed, it is a conserved feature that c
tmeiotic cells monitor various stages of recombination
and a failure to complete recombination induces mei- w
sotic arrest in yeasts and apoptosis in mammals (Odori-
sio et al., 1998; Schwartz et al., 1999; Roeder and Bailis, r
t2000; Cohen and Pollard, 2001; Lydall et al., 1996). In
C. elegans this checkpoint becomes dramatically mani- q
tfested when meiotic double-strand breaks that are in-
duced by SPO-11 are not properly processed due to p
pinactivation of the conserved RAD-51 (RecA) single-trand exchange protein (Gartner et al., 2000; Alpi et
l., 2003; Colaiacovo et al., 2003). Taken together, we
uggest the following model: The translation of cep-1/
53 is completely repressed in transition zone nuclei
here multiple double-strand breaks per chromosome
re induced (Alpi et al., 2003; Bishop, 1994) and in early
achytene cells where double-strand breaks are pro-
essed and recombinational exchanges are restricted
o a single site per chromosome (Hillers and Villeneuve,
003). This might be part of a fail-safe mechanism to
nsure that meiotic double-strand breaks or their inter-
ediates do not mistakenly trigger the apoptotic de-
ise of germ cells that are undergoing exchange be-
ween homologous chromosomes. CEP-1/p53 then
ecomes available again in late pachytene when mei-
tic recombination is supposed to be finished and cells
arboring aberrant recombination intermediates can be
liminated through CEP-1/p53. Interestingly, mamma-
ian p53 is similarly implicated in the apoptotic demise
f meiotic pachytene cells upon DNA damage (Hase-
awa et al., 1998; Sjoblom and Lahdetie, 1996; Odorisio
t al., 1998), and presumably this activity must be
locked during the normal course of meiotic recombi-
ation. Therefore, it is possible that p53 might be simi-
arly regulated at the translational level by mRNA bind-
ng proteins in mammalian gametogenesis. It has been
hown previously that in cell culture-based systems, an
lement in the 3#UTR of human p53 is necessary for
53 translational control in OCI/AML-3 and OCI/AML-4
ells (Fu and Benchimol, 1997; Fu et al., 1999). Similarly,
n mouse Swiss 3T3 cells it has been shown that the
#UTR of p53 mediates translational repression (Mosner
t al., 1995).
Translational repression by GLD-1 is important for
ell fate choices—the proliferation versus initiation of
eiotic development decision, the spermatogenesis
ersus oogenesis decision, and, as shown in this study,
he pachytene progression versus apoptosis decision.
he diverse germline functions of GLD-1 are a conse-
uence of its regulation of multiple mRNA targets (Lee
nd Schedl, 2001, 2004; Jan et al., 1999; Marin and Ev-
ns, 2003; Xu et al., 2001; Mootz et al., 2004). Similar to
ld-1 genetics, mutations in GLD-1 homologs in other
pecies show complex phenotypes. Drosophila WHO/
OW and mammalian Quaking are required for viability
Zaffran et al., 1997; Baehrecke, 1997; Bode, 1984; Jus-
ice and Bode, 1988; Shedlovsky et al., 1988), and hy-
omorphic alleles of mouse Quaking show defects in
yelination and in vascular development (Sidman et
l., 1964; Samorajski et al., 1970). This suggests that
LD-1 GSG/STAR protein family members in other spe-
ies likewise regulate a number of different target
RNAs. Our results demonstrate the power of a for-
ard genetic approach that revealed a specific process
ontrolled by a multifunctional regulator. The identifica-
ion of a separation-of-function mutation of gld-1,
hich appears to have lost its capacity to bind to a
ubset of mRNA targets, including the cep-1 mRNA,
eveals an unexpected link between the cell fate regula-
or GLD-1 and p53 DNA damage signaling. It will re-
uire further studies to establish the importance of
ranslational repression of p53 or its family members
63 and p73, in intact mammalian tissues, which could
otentially act through the mammalian GLD-1 homolog
Translational Repression of C. elegans p53 by GLD-1
367Quaking or through other GSG/STAR family proteins.
Such negative p53 regulation by translational repres-
sion might provide a novel target for tumor therapies
aiming at upregulating p53 signaling.
Experimental Procedures
C. elegans DNA Damage Response Assays
The detailed experimental procedures for scoring DNA damage-
induced apoptosis and mitotic cell cycle arrest, as well as for
radiation survival (rad) assays and egl-1 transcriptional assays are
described by Gartner et al. (2004). For rad assays worms were irra-
diated at L4 larval stage and transferred to fresh plates 24 hr post-
treatment and removed from the plates after 12 hr (Gartner et al.,
2000). For irradiation an X-ray source Siemens “Stabilipan” was
used. rad-51 RNAi was performed as described in Gartner et al.
(2004).
Genetic Screen for Increased Apoptosis
upon Ionizing Radiation
Standard mutagensis conditions were used (Wood, 1996), and
germ cell apoptosis was evaluated in F2 worms 28 to 32 hr post IR
treatment by staining apoptotic corpses with acridine orange (AO)
(Gartner et al., 2004).
Strains
Worms were maintained and raised at 20°C on NGM plates unless
otherwise indicated. ced-3(n717) is described by Yuan et al. (1993),
ced-4(n1162) by Yuan and Horvitz (1992), ced-9(n1950) by Hen-
gartner et al. (1992), egl-1(n1084n3082), referred to as egl-1 in this
manuscript, by Conradt and Horvitz (1998), ced-1(e1935) by Zhou
et al. (2001), and rad-5(mn159) by Ahmed et al. (2001). The genetic
null gld-1(q485) mutant referred to as gld-1(null) was described by
Francis et al. (1995a). The deletion mutant cep-1(lg12501), referred
to as cep-1/p53, carries a 1213 bp deletion corresponding to
30458–31670 on cosmid F52B5 and takes out a large part of the
cep-1 open reading frame. The CED-1::GFP (bcIs39) V strain is a
gift from Barbara Conradt.
Supplemental Data
Supplemental Data include six figures and are available with this
article online at http://www.cell.com/cgi/content/full/120/3/357/
DC1/.
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